News on Medial

Portea’s revenue stays flat in FY23; losses grow 32%

EntrackrEntrackr · 1y ago
Portea’s revenue stays flat in FY23; losses grow 32%
Medial

Home healthcare solution provider Portea has been struggling to scale which is evident from its stagnant growth in FY23. At the same time, the Accel-backed firm’s losses grew 32% during the fiscal year ending March 2023. Portea’s revenue from operations declined 3.3% to Rs 145 crore in FY23 from Rs 150 crore in FY22, its annual consolidated financial statements filed with the Registrar of Companies show. Portea brings quality medical care into patients’ homes to make primary healthcare accessible and accountable. Income from the products used and services offered to the patients were the primary source of revenue for the company. As per Portea’s website, the company has provided services to over 1 million patients and conducts 700,000 patient visits annually. Additionally, it has established partnerships with 63 leading hospitals. For the home healthcare provider, the consumables used for patient treatment and employee benefits jointly formed more than half (51%) of its overall expenditure. These costs stood at Rs 55 crore and Rs 50 crore respectively during FY23. Its consultancy fees, advertising cum promotional, traveling, legal, information/technology, and other overheads catalyzed the overall expenditure to Rs 206 crore in FY23 from Rs 204 crore in FY22. View TheKredible for the complete expense breakdown Expenses Breakdown Total ₹ 204 Cr https://thekredible.com/company/portea/financials View Full Data To access complete data, visithttps://thekredible.com/company/portea/financials Total ₹ 206 Cr https://thekredible.com/company/portea/financials View Full Data To access complete data, visithttps://thekredible.com/company/portea/financials Employee benefit Employee benefit Cost of material consumed Cost of material consumed Advertising promotional Advertising promotional Consultancy expenses Consultancy expenses Travelling conveyance Travelling conveyance Information technology Information technology Others To check complete Expense Breakdown visit thekredible.com View full data The stagnant scale and fixed overheads led Portea to register a Rs 53 crore loss during FY23 where the figures stood at Rs 40 crore in FY22. Its ROCE and EBITDA margins stood at -94% and -27.5%, respectively. On a unit level, Portea spent Rs 1.42 to earn a rupee in FY23. Caveat: We have excluded an exceptional item of Rs 20.5 crore while calculating the bottom line for FY23. Portea has raised around $90 million across several rounds. According to the startup data intelligence platform TheKredible, Accel is the largest external stakeholder with 32.38% followed by Ventureast, MEMG, and Qualcomm. Head to TheKredible for the complete shareholding pattern. FY22-FY23 FY22 FY23 EBITDA Margin -20% -27.5% Expense/₹ of Op Revenue ₹1.36 ₹1.42 ROCE -206% -94% Founded by Meena Ganesh and Ganesh Krishnan, after their successful exit from Tutorvista in 2011, Portea benefited from the reputation of its founder to attract strong investor interest. It did well enough to even consider an IPO in 2022, before hitting a wall. While blaming Covid would be an obvious excuse here, we believe the firm actually had its chance to build a reputation during and post the pandemic, even if at a higher temporary cost, but fluffed it. For now, it seems like a promising business on a standalone basis, but will be weighed down by its long decade plus legacy. With its last funding raised in 2021, Portea faces a moment of reckoning, and it remains to be seen if the founder’s experience with compelling narratives and exits will come to its rescue soon.

Related News

Toothsi parent MakeO reports flat revenue in FY24; losses trim 32%

EntrackrEntrackr · 6m ago
Toothsi parent MakeO reports flat revenue in FY24; losses trim 32%
Medial

Toothsi parent MakeO reports flat revenue in FY24; losses trim 32% Following over twofold growth in FY23, MakeO, the parent company of Toothsi and skincare brand Skinnsi, reported stable revenue for the fiscal year ending March 2024, but succeeded in reducing its losses by 32%. MakeO’s revenue from operations saw a modest increase of 6.5% to Rs 179 crore in FY24 from Rs 168 crore in FY23, according to its consolidated financial statements filed with the Registrar of Companies. Founded in 2018 by Arpi Mehta Shah, Pravin Shetty, Manjul Jain, and Anirudh Kal, MakeO began as the aligner brand Toothsi and later consolidated its flagship brands, including Skinnsi, to offer dental, skin, and hair treatment solutions. The sale of tooth aligners accounted for 69.2% of the operating revenue, increasing by 7% to Rs 124 crore in FY24. The rest of the revenue came from Skinnsi services, including laser hair reduction, facials, anti-aging treatments, and skincare products. Employee benefits remained the largest cost center at 36% of overall expenditure, amounting to Rs 119 crore in FY24. Consultant fees and marketing costs were reduced by 57% and 24%, respectively, to Rs 26 crore and Rs 69 crore in FY24. Other expenses totaled Rs 332 crore in FY24, down from Rs 395 crore in FY23. The cutback in costs helped MakeO reduce its losses by 31.8% to Rs 150 crore in FY24 from Rs 220 crore in FY23. Its ROCE and EBITDA margin stood at -77.3% and -66.12% with an expense-to-earnings ratio of Rs 1.85. At the end of FY24, MakeO’s current assets were Rs 153 crore with cash and bank balances of Rs 93 crore. MakeO has raised over $90 million to date, including $16 million led by 360 One Asset and the investment office of Ashish Kacholia. Eight Roads Ventures is the largest external stakeholder, followed by Think Investment.

Oziva records flat growth under Hindustan Unilever in FY24

EntrackrEntrackr · 1y ago
Oziva records flat growth under Hindustan Unilever in FY24
Medial

D2C nutrition brand Oziva, which was acquired by FMCG giant Hindustan Unilever (HUL) in 2022, posted a flat scale during the fiscal year ending March 2024. Following a 20% decline in sales during FY23, the D2C nutrition brand posted a flat scale with a modest 4% increase to Rs 104 crore in FY24, the annual report of its parent company HUL shows. HUL said that Oziva recorded Rs 44 crore loss in the last fiscal year. In FY23, the firm registered a net profit of Rs 58.8 crore due to one-time gain of Rs 95.5 crore. However, if we exclude that other income, its losses stood at Rs 45.8 crore in FY23. This implies, Oziva’s scale and loss remained flat in the last financial year (FY24). It’s worth noting that it is the first full fiscal year for Oziva under Hindustan Unilever. The six-year-old D2C firm sells plant-based nutrition products for health, skin, hair, and general wellness. The sale of health and nutrition products was the sole revenue driver for the company. The company has raised around $17 million to date with the backing of Matrix Partners, Eight Road Ventures, and Stride Ventures. In December 2022, HUL acquired 51% stake in Oziva with the first tranche at a cash consideration of Rs 264.28 crore ($32 million). As per the annual report, Oziva was valued at Rs 361 crore ($43.5 million) using the multi-period excess earnings method. At the same time, HUL also acquired 19.8% of the stake in Wellbeing Nutrition for a cash consideration of Rs 70 crore. Founded by Avnish Chhabria, Wellbeing Nutrition is a whole-food nutrition company that uses plant-based ingredients to deliver wellness to individuals. The company is yet to disclose its FY24 results.

Ergos gross revenue crosses Rs 200 Cr in FY23; losses stagnant

EntrackrEntrackr · 1y ago
Ergos gross revenue crosses Rs 200 Cr in FY23; losses stagnant
Medial

Agritech platform Ergos has managed to grow its scale by two-thirds in the fiscal year ending March 2023 with sound economics as the Bengaluru-based company kept losses in check during the period. Ergos’ gross revenue grew 66% to Rs 224 crore in FY23 from Rs 135 crore in FY22, its annual financial statements (FY23) filed with the Registrar of Companies show. Ergos enables farmers to convert their grains into tradable assets, access credit against stored produce, and make better yields. It also provides harvest supply chain solutions by leveraging technology. The sale of commodities to the customer was the primary source of revenue for Ergos contributing to 96% of overall operating income. Wheat turned out to be the largest revenue driver followed by maize, paddy, and others. Rest of the revenue came from warehousing management fees. Visit TheKredible for a detailed revenue breakup. On the expenses side, procurement costs formed 64.8% of the overall expenditure which spiked 65% to Rs 211 crore in FY23. Other costs such as employee benefits, rent, professional, vehicle and traveling costs took its overall expenditure to Rs 249 crore in FY23 from Rs 160 crore in FY22. Head to TheKredible for a complete expense breakup. The decent growth in scale and effective cost mechanism helped Ergos to control its losses which stood at Rs 24 crore in FY23 as compared to Rs 23 crore in FY22. Its ROCE and EBITDA margin stood at -69% and -8.9% respectively. On a unit level, Ergos spent Rs 1.11 to earn a rupee in FY23. FY22-FY23 FY22 FY23 EBITDA Margin -16% -8.9% Expense/₹ of Op Revenue ₹1.19 ₹1.11 ROCE -44% -69% As of now, Ergos has raised around $32 million across several rounds and was last valued at around $55 million. According to the startup data intelligence platform TheKredible, Aavishkaar Capital is the largest stakeholder with 48% followed by Chiratae Ventures and CDC Group. Currently, its founder and chief executive officer Kishor Kumar Jha commands 11.84% of the company. Operating to provide farmers avenues beyond MSP procurement one assumes, Ergos ses to be on a good pitch to leverage inefficiencies in the supply chain. However, one has to wonder just how far and high the model can take the firm. Perhaps a move into other crops will follow once enough of a network and learnings have been built in.

Download the medial app to read full posts, comements and news.